Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.01B |
| 2 |
Humana
HUM
|
+$659M |
| 3 |
Apple
AAPL
|
+$579M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
Home Depot
HD
|
+$508M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$744M |
| 2 |
McDonald's
MCD
|
+$604M |
| 3 |
Cigna
CI
|
+$500M |
| 4 |
Digital Realty Trust
DLR
|
+$424M |
| 5 |
Amazon
AMZN
|
+$407M |
Sector Composition
| 1 | Technology | 19.72% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 10.08% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFR
5176
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
| $24.5K | ﹤0.01% |
+144,346
| New | +$24.5K |
|
|
OMIC
5177
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $24.3K | ﹤0.01% |
2,127
+1,182
| +125% | +$13.5K |
|
5178
Aware
AWRE
$58M
| $24.2K | ﹤0.01% |
17,514
-3,257
| -16% | -$4.5K |
|
5179
Greenlane Holdings
GNLN
$4.92M
| $24.2K | ﹤0.01% |
4
+1
| +33% | +$6.04K |
|
|
MOGO
5180
Mogo
MOGO
$47M
| $23.8K | ﹤0.01% |
15,143
+9,826
| +185% | +$15.4K |
|
|
ENTO
5181
Entero Therapeutics
ENTO
$8.2M
| $23.7K | ﹤0.01% |
+1,364
| New | +$23.7K |
|
|
PTPI
5182
DELISTED
Petros Pharmaceuticals
PTPI
| $23.7K | ﹤0.01% |
+572
| New | +$23.7K |
|
5183
LifeVantage
LFVN
$135M
| $23.5K | ﹤0.01% |
3,649
-12,195
| -77% | -$78.7K |
|
5184
China SXT Pharmaceuticals
SXTC
$226M
| $23.5K | ﹤0.01% |
+957
| New | +$23.5K |
|
5185
Manchester United
MANU
$2.62B
| $23.5K | ﹤0.01% |
+1,187
| New | +$23.5K |
|
|
SAIH
5186
SAIHEAT Ltd
SAIH
$18.3M
| $23.4K | ﹤0.01% |
1,657
+557
| +51% | +$7.85K |
|
5187
Ascendis Pharma
ASND
$12B
| $23.2K | ﹤0.01% |
248
-13,724
| -98% | -$1.29M |
|
5188
Brookfield Infrastructure
BIPC
$4.85B
| $23.2K | ﹤0.01% |
+656
| New | +$23.2K |
|
|
USDP
5189
DELISTED
USD PARTNERS LP
USDP
| $23.2K | ﹤0.01% |
+38,585
| New | +$23.2K |
|
5190
Gyre Therapeutics
GYRE
$658M
| $23.1K | ﹤0.01% |
+3,198
| New | +$23.1K |
|
|
DHY
5191
Credit Suisse High Yield Credit Fund
DHY
$218M
| $22.7K | ﹤0.01% |
+12,075
| New | +$22.7K |
|
|
HYFT
5192
MindWalk Holdings
HYFT
$79.9M
| $22.7K | ﹤0.01% |
12,381
-22,402
| -64% | -$41K |
|
5193
INNOVATE Corp
VATE
$67.2M
| $22.5K | ﹤0.01% |
+1,389
| New | +$22.5K |
|
|
TBHC
5194
The Brand House Collective
TBHC
$41.3M
| $22.5K | ﹤0.01% |
13,053
-14,184
| -52% | -$24.4K |
|
5195
Nautilus Biotechnolgy
NAUT
$86M
| $22.3K | ﹤0.01% |
7,058
+2,316
| +49% | +$7.32K |
|
|
MTVA
5196
MetaVia Inc
MTVA
$25.2M
| $22.1K | ﹤0.01% |
+5,797
| New | +$22.1K |
|
5197
Sol-Gel Technologies
SLGL
$85M
| $21.9K | ﹤0.01% |
1,344
-431
| -24% | -$7.03K |
|
5198
Comstock
LODE
$158M
| $21.8K | ﹤0.01% |
5,326
+4,417
| +486% | +$18.1K |
|
|
SNT
5199
Senstar Technologies
SNT
$105M
| $21.8K | ﹤0.01% |
19,644
+1,984
| +11% | +$2.2K |
|
5200
Akanda
AKAN
$2.56M
| $21.6K | ﹤0.01% |
+163
| New | +$21.6K |
|